**Core Concept**
Myocardial infarction (MI) occurs when there is a sudden loss of coronary blood flow, leading to ischemic damage to cardiac muscle. This results in the release of cardiac biomarkers, including creatine kinase-myocardial band (CK-MB) and troponin, into the bloodstream.

**Why the Correct Answer is Right**
In the context of ST segment elevation in the ECG, increased CK-MB and troponin levels are indicative of myocardial necrosis, which is characteristic of an ST-elevation myocardial infarction (STEMI). The release of these enzymes is due to the breakdown of cardiac tissue, which leads to the leakage of intracellular enzymes into the bloodstream. This process is mediated by the activation of various cellular pathways, including the caspase cascade, which ultimately leads to cell death.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is not relevant to the scenario described, as it does not explain the increase in cardiac biomarkers in the context of myocardial infarction.
**Option B:** While muscle damage can lead to increased levels of certain enzymes, such as creatine kinase, the specific pattern of enzyme elevation seen in this case (CK-MB and troponin) is characteristic of cardiac rather than skeletal muscle damage.
**Option C:** This option is incorrect because it does not accurately describe the underlying mechanism leading to the increase in cardiac biomarkers in the context of myocardial infarction.

**Clinical Pearl / High-Yield Fact**
Remember that the combination of ST segment elevation on ECG, increased CK-MB and troponin levels, and symptoms of chest pain radiating to the left arm is highly suggestive of an ST-elevation myocardial infarction (STEMI). Early recognition and treatment of STEMI are critical to minimize cardiac damage and improve patient outcomes.

**Correct Answer:** C. Rupture of cardiac myocytes leading to leakage of intracellular enzymes into the bloodstream.